First Manhattan CO Eli Lilly & CO Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

A detailed history of First Manhattan CO transactions in Eli Lilly & CO stock. As of the latest transaction made, First Manhattan CO holds 59,466 shares of LLY stock, worth $44.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

59,466

Previous 61,968 4.04%

Holding current value

$44.5 Million

Previous $56.1 Million 6.1%

% of portfolio

0.16%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $1.93 Million - $2.4 Million	-2,502 Reduced 4.04%	59,466 $52.7 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $6.17 Million - $7.73 Million	8,506 Added 15.91%	61,968 $56.1 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $3.04 Million - $4.06 Million	-5,129 Reduced 8.75%	53,462 $41.6 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $51,993 - $61,293	99 Added 0.17%	58,591 $34.2 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $996,767 - $1.37 Million	-2,293 Reduced 3.77%	58,492 $31.4 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $8.25 Million - $11 Million	-23,535 Reduced 27.91%	60,785 $28.5 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.16 Million - $1.37 Million	-3,750 Reduced 4.26%	84,320 $29 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $10.6 Million - $12.4 Million	-33,078 Reduced 27.3%	88,070 $32.2 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $3.11 Million - $3.55 Million	-10,502 Reduced 7.98%	121,148 $39.2 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $23,692 - $27,817	-85 Reduced 0.06%	131,650 $42.7 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $1.23 Million - $1.52 Million	5,223 Added 4.13%	131,735 $37.7 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $4.19 Million - $5.2 Million	18,618 Added 17.26%	126,512 $34.9 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $48,087 - $59,178	-217 Reduced 0.2%	107,894 $24.9 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $542,552 - $701,787	-3,005 Reduced 2.7%	108,111 $24.8 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.11 Million - $1.44 Million	6,766 Added 6.48%	111,116 $20.8 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $137,635 - $182,124	-1,055 Reduced 1.0%	104,350 $17.6 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $52,492 - $60,717	359 Added 0.34%	105,405 $15.6 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $46,109 - $55,492	-338 Reduced 0.32%	105,046 $17.2 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $150,122 - $185,808	-1,261 Reduced 1.18%	105,384 $14.6 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $571,594 - $707,970	-5,346 Reduced 4.77%	106,645 $14 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $440,401 - $479,043	-4,124 Reduced 3.55%	111,991 $12.5 Million
Q2 2019 Aug 16, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Reduced 0.09%	116,115 $12.9 Million
Q1 2019 Apr 12, 2019	SELL	$111.31 - $131.02 $482,083 - $567,447	-4,331 Reduced 3.59%	116,215 $15.1 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $110,665 - $123,978	-1,045 Reduced 0.86%	120,546 $13.9 Million
Q3 2018 Oct 15, 2018	SELL	$85.86 - $107.31 $100,456 - $125,552	-1,170 Reduced 0.95%	121,591 $13 Million
Q2 2018 Aug 01, 2018	SELL	$75.7 - $86.88 $52,990 - $60,816	-700 Reduced 0.57%	122,761 $10.5 Million
Q1 2018 Apr 20, 2018	SELL	$74.21 - $87.6 $76,362 - $90,140	-1,029 Reduced 0.83%	123,461 $9.55 Million
Q4 2017 Jan 22, 2018	BUY	$81.94 - $87.89 $32,366 - $34,716	395 Added 0.32%	124,490 $10.5 Million
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $9.56 Million - $10.6 Million	124,095	124,095 $10.6 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Eli Lilly & CO Transaction History